India's envoy to Russia, DB Venkatesh Varma has announced that Sputnik V's production will start in India in August. This will tremendously boost India's vaccination campaign.
"Production in India is expected to start in August. 850 million doses of the Sputnik V vaccine will be produced in India by about September-October," said Envoy Venkatesh Varma, speaking to a group of reporters during his Saint Petersburg visit.
He also said that almost 65 to 70 percent of Sputnik V vaccine produced anywhere in the world will be from India, and once Indian demand is met, Russia will also export it to other parts. The Russian sovereign wealth fund Russian Direct Investment Fund (RDIF), which has funded the vaccine, has signed a pact with five Indian companies for production in India.
India has already received 210,000 doses of Sputnik V vaccine earlier this month and by the end of May, it will get 3 million doses in the form of bulk for fill and finish mode, which means the vaccines will be filled in bottles in India, and finally, the Russian side will transfer technology to Indian companies for full production in India. By June, this number will increase to 5 million.
Currently, Sputnik V, Covishield, and COVAXIN are the only three Covid vaccines allowed for use in India.
"Production in India is expected to start in August. 850 million doses of the Sputnik V vaccine will be produced in India by about September-October," said Envoy Venkatesh Varma, speaking to a group of reporters during his Saint Petersburg visit.
He also said that almost 65 to 70 percent of Sputnik V vaccine produced anywhere in the world will be from India, and once Indian demand is met, Russia will also export it to other parts. The Russian sovereign wealth fund Russian Direct Investment Fund (RDIF), which has funded the vaccine, has signed a pact with five Indian companies for production in India.
India has already received 210,000 doses of Sputnik V vaccine earlier this month and by the end of May, it will get 3 million doses in the form of bulk for fill and finish mode, which means the vaccines will be filled in bottles in India, and finally, the Russian side will transfer technology to Indian companies for full production in India. By June, this number will increase to 5 million.
Currently, Sputnik V, Covishield, and COVAXIN are the only three Covid vaccines allowed for use in India.
